Hester Biosciences Ltd
NSE: HESTERBIO BSE: 524669
₹2196.40
+38.70 (1.79%)
Sat, 24 Oct 2026, 01:44 am
Market Cap (in Cr)1826.59
PE Ratio13.72
Dividend0.51
Health Technology
Pharmaceuticals: Major
24.5KHester Biosciences Income Statement
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 200.84M | 208.49M | 314.28M | 291.22M | 374.78M | 418.51M | 481.61M | 649.27M | 686.91M | 902.44M | 1.01B | 1.23B | 1.36B | 1.78B | 1.83B | 2.14B | 2.35B | 2.66B | 3.03B | 3.11B |
| Gross profit | 131.98M | 83.56M | 184.93M | 163.29M | 169.95M | 196.84M | 218.98M | 270.19M | 314.80M | 363.73M | 469.70M | 561.50M | 621.76M | 849.41M | 814.51M | 927.10M | 856.28M | 865.25M | 957.81M | 1.14B |
| Operating expenses (excl. COGS) | -46.88M | -2.07M | -52.20M | -54.22M | -50.39M | -60.73M | -72.95M | -93.43M | -117.24M | -171.10M | -189.32M | -216.85M | -241.94M | -282.47M | -387.08M | -359.26M | -419.85M | -554.98M | -593.04M | -682.20M |
| Selling/general/admin expenses, total | -45.98M | — | -51.67M | -53.71M | -50.39M | -60.73M | -72.95M | -93.43M | -119.13M | -171.10M | -189.32M | -216.85M | -234.35M | -260.40M | -381.78M | -348.13M | -415.26M | -547.94M | -581.07M | -657.73M |
| Research & development | 0 | 0 | 0 | 0 | 0 | — | -11.29M | -5.95M | -12.83M | -32.04M | -41.13M | -28.34M | -28.77M | -31.74M | -24.04M | -10.24M | — | — | -46.65M | -59.52M |
| Selling/general/admin expenses, other | -45.98M | — | -51.67M | -53.71M | -50.39M | -60.73M | -61.66M | -87.48M | -106.30M | -139.05M | -148.19M | -188.51M | -205.57M | -228.66M | -381.78M | -337.89M | -415.26M | -547.94M | -581.07M | -598.21M |
| Other operating expenses, total | -897.60K | -2.07M | -525.00K | -517.00K | 0 | 0 | 0 | 0 | 1.89M | 0 | 0 | 0 | -7.59M | -22.07M | -5.30M | -11.13M | -4.59M | -7.04M | -11.97M | -24.47M |
| Operating income | 85.10M | 81.49M | 132.74M | 109.06M | 119.55M | 136.11M | 146.04M | 176.76M | 197.56M | 192.64M | 280.38M | 344.65M | 379.82M | 566.93M | 427.43M | 567.84M | 436.43M | 310.27M | 364.77M | 455.05M |
| Non-operating income, total | -17.36M | -2.73M | -24.17M | -28.06M | -23.55M | -24.60M | -27.07M | -32.70M | -63.88M | -22.80M | -32.30M | -35.31M | -18.60M | 1.63M | -14.17M | -66.81M | 94.36M | 47.18M | -91.33M | -100.34M |
| Interest expense, net of interest capitalized | -1.48M | -5.94M | -24.87M | -26.49M | -21.33M | -23.17M | -28.28M | -32.64M | -40.73M | -48.23M | -33.72M | -34.99M | -40.36M | -66.34M | -73.70M | -66.04M | -35.33M | -54.80M | -94.29M | -88.26M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | -999.15K | 3.21M | 698.84K | -1.57M | -2.23M | -1.42M | 1.42M | 77.62K | -21.16M | 6.44M | 1.42M | -37.06K | 21.76M | 68.80M | 59.53M | -770.00K | 129.69M | 101.98M | -8.81M | -13.07M |
| Non-operating interest income | 207.49K | 2.49M | 1.45M | 388.48K | 454.21K | 786.63K | 1.28M | 1.43M | 1.90M | 1.25M | 1.14M | 696.07K | 809.66K | 1.52M | 3.73M | 12.94M | 19.03M | 21.73M | 19.07M | 20.37M |
| Miscellaneous non-operating expense | -1.21M | 724.85K | -748.98K | -1.96M | -2.68M | -2.21M | 136.30K | -1.35M | -23.06M | 5.19M | 278.34K | -733.13K | 20.95M | 14.46M | 19.69M | -36.94M | -190.00K | -32.83M | -80.75M | -38.51M |
| Unusual income/expense | -14.87M | — | — | — | — | — | -206.52K | -132.75K | -1.99M | 19.00M | — | -289.13K | — | -828.58K | 0 | 0 | 0 | 0 | 11.77M | 990.00K |
| Pretax income | 67.74M | 78.76M | 108.57M | 81.01M | 96.00M | 111.52M | 118.97M | 144.07M | 133.68M | 169.84M | 248.08M | 309.34M | 361.22M | 568.56M | 413.26M | 501.03M | 530.79M | 357.45M | 273.44M | 354.71M |
| Taxes | -23.30M | -27.25M | -38.16M | -33.64M | -35.67M | -35.88M | -44.11M | -53.37M | -42.03M | -48.17M | -56.26M | -81.47M | -130.54M | -161.62M | -103.24M | -154.05M | -140.18M | -121.19M | -107.87M | -107.45M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 1.22M | 1.89M | 2.89M | 2.99M | 144.11K | 7.58M | 25.54M | 8.74M | -18.31M | -2.68M | -1.64M | -14.08M | -22.77M | -13.38M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 44.45M | 51.51M | 70.41M | 47.36M | 60.33M | 75.64M | 76.09M | 92.59M | 94.54M | 124.66M | 191.96M | 235.45M | 256.21M | 415.67M | 291.71M | 344.30M | 393.20M | 266.27M | 188.89M | 274.88M |
| Net income | 44.45M | 51.51M | 70.41M | 47.36M | 60.33M | 75.64M | 76.09M | 92.59M | 94.54M | 124.66M | 191.96M | 235.45M | 256.21M | 415.67M | 291.71M | 344.30M | 393.20M | 266.27M | 188.89M | 274.88M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 44.45M | 51.51M | 70.41M | 47.36M | 60.33M | 75.64M | 76.09M | 92.59M | 94.54M | 124.66M | 191.96M | 235.45M | 256.21M | 415.67M | 291.71M | 344.30M | 393.20M | 266.27M | 188.89M | 274.88M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 88.64M | 85.90M | 169.58M | 147.50M | 161.89M | 180.89M | 187.27M | 221.08M | 251.71M | 251.81M | 337.90M | 414.67M | 476.41M | 684.49M | 558.15M | 700.98M | 602.24M | 517.22M | 536.51M | 623.07M |
| EBIT | 85.10M | 81.49M | 132.74M | 109.06M | 119.55M | 136.11M | 146.04M | 176.76M | 197.56M | 192.64M | 280.38M | 344.65M | 379.82M | 566.93M | 427.43M | 567.84M | 436.43M | 310.27M | 364.77M | 455.05M |
| Total operating expenses | -115.74M | -126.99M | -181.54M | -182.15M | -255.23M | -282.40M | -335.57M | -472.51M | -489.35M | -709.80M | -724.78M | -883.28M | -976.80M | -1.21B | -1.41B | -1.58B | -1.91B | -2.35B | -2.67B | -2.65B |
| Prepaid expenses | 36.99M | 57.20M | 90.67M | 90.73M | 101.01M | 73.23M | 534.77K | 3.88M | — | 3.87M | — | 2.10M | 4.77M | 1.72M | 7.64M | 9.87M | 23.90M | 12.83M | 15.93M | 16.80M |
| Deferred income, current | — | — | — | — | — | — | — | — | 1.68M | 3.60M | 995.78K | 1.76M | 1.95M | 4.91M | 4.29M | 39.73M | 6.49M | 92.35M | 9.89M | 5.67M |
| Capital and operating lease obligations | 4.36M | 3.08M | 3.76M | 3.32M | 7.03M | 7.93M | 3.01M | 2.74M | 3.29M | 5.65M | 6.50M | 2.89M | 2.89M | 2.50M | 56.30M | 56.30M | 738.91M | 943.50M | 54.75M | 54.75M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 8.74M | 16.81M | 18.97M | 26.16M | 27.01M | 25.83M | 24.93M | 26.57M | 50.24M | 54.41M | 80.63M | 88.10M | 100.98M | 106.60M | 88.17M | 76.25M | 72.64M | 83.64M | 86.28M | 90.59M |
| Deferred income, non-current | 0 | 0 | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | 0 | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 6.66M | 13.00M | 11.96M | 12.77M | 14.63M | 46.45M | 45.99M | 43.68M | 36.97M | 54.21M | 76.50M | 74.09M | 88.16M | 110.82M | 124.01M |
| Change in accrued expenses | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -10.91M | -5.56M | -10.38M | -12.98M | -12.98M | -14.79M | -18.17M | -5.72M | -19.91M | -19.75M | -62.49M | -41.98M | -64.50M | -102.55M | -71.79M | -56.15M | -85.07M | -85.07M | -68.53M | -51.68M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
